login
login
Image header Agence Europe
Europe Daily Bulletin No. 13053
Contents Publication in full By article 21 / 28
EU RESPONSE TO COVID-19 / Health

EMA publishes clinical trial supporting use of Comirnaty vaccine as a booster dose for children aged 5 to 11 years

Brussels, 28/10/2022 (Agence Europe) – On Tuesday 25 October, the European Medicines Agency (EMA) announced the publication of the clinical trial supporting the use of Comirnaty, the mRNA SARS-CoV-2 vaccine developed by the pharmaceutical companies Pfizer and BioNTech, as a booster dose for children aged 5 to 11 years. The EMA specifies that the publication of these clinical trials is done under the exceptional measures related to the Covid-19 epidemic. These exceptional measures were implemented to improve the transparency of its regulatory process for vaccines approved or under evaluation. You need to create an account on the EMA website in order to access this data. Link to the clinical trial: https://aeur.eu/f/3tz (EV)

Contents

SECTORAL POLICIES
TRANSPORT: European Parliament and EU Council reach provisional political agreement on CO2 emission standards for new cars and vans
SPACE: EU and ESA budgetary commitments must be consistent with challenges of European sovereignty, says ArianeGroup CEO
FISHERIES: European Commission proposes six-month closure of eel fisheries in 2023
AGRICULTURE: European Commission has approved CAP strategic plans of Croatia, Slovenia and Sweden
CLIMATE: world on track for 2.8°C of warming by end of century, warns United Nations
ENERGY: Norway reaffirms opposition to gas price cap
DIGITAL: Czech Presidency of EU Council clarifies digital identity wallet certification processes
SINGLE MARKET: deepening the single market for services remains concern at time of 30th anniversary
COHESION: Loire Atlantique and Malta adopt their Territorial Plans for a Just Transition
Russian invasion of Ukraine
STATE AID: European Commission prolongs and amends Temporary Crisis Framework
STATE AID: Belgium gives green light for €1.5 billion in aid to support energy suppliers in context of war in Ukraine
EXTERNAL ACTION
BOSNIA AND HERZEGOVINA: Ursula von der Leyen calls on newly elected politicians to unite to move forward on European path
SERBIA: Ursula von der Leyen announces €165 million in support to cope with energy crisis
IRAN: EU denounces sanctions against MEPs
UZBEKISTAN: EU wants to increase economic exchanges with Tashkent
LATIN AMERICA: Europe and Latin America want to reinvigorate bilateral relations for peace and economic progress
NIGER: European diplomatic service outlines policy priorities for enhanced cooperation with a key partner in Sahel
DEVELOPMENT: MEPs call for alignment of financing for development with SDGs and Paris Agreement on climate
ACP: Climate change and access to raw materials market for African countries on agenda of 42nd ACP-EU Joint Parliamentary Assembly
EU RESPONSE TO COVID-19
HEALTH: MEPs wanted more transparency in negotiations leading up to vaccine purchases and will re-invite Albert Bourla
HEALTH: EMA publishes clinical trial supporting use of Comirnaty vaccine as a booster dose for children aged 5 to 11 years
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
GENDER EQUALITY: proposed directive to combat gender-based violence addresses shortcomings of current European legislation
ECONOMY - FINANCE - BUSINESS
TAXATION: MEPs want to protect whistleblowers and investigative journalists following ‘Pandora Papers’
COURT OF JUSTICE OF THE EU
GMO: random in vitro mutagenesis must be excluded from GMO legislation, says Advocate General of EU Court of Justice
NEWS BRIEFS
AGRICULTURE: rapporteur in European Parliament’s Committee on Agriculture on sustainable use of pesticides will be from S&D
TRADE: EU extends anti-dumping duties on certain Chinese and Russian steel products
ITALY: Giorgia Meloni in Brussels on Thursday 3 November
MOLDOVA: EU-Chisinau agreement to facilitate certain customs procedures enters into force in November